$ONC
BeiGene, Ltd.

2024 Q4 Form 10-Q Financial Statement

#000165130824000152 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $1.002B
YoY Change 28.2%
Cost Of Revenue
YoY Change
Gross Profit $831.1M
YoY Change 21.33%
Gross Profit Margin 82.98%
Selling, General & Admin $455.2M
YoY Change 24.92%
% of Gross Profit 54.77%
Research & Development $496.2M
YoY Change 9.47%
% of Gross Profit 59.7%
Depreciation & Amortization $70.03M
YoY Change 263.93%
% of Gross Profit 8.43%
Operating Expenses $951.4M
YoY Change 16.35%
Operating Profit -$120.3M
YoY Change -10.23%
Interest Expense $10.64M
YoY Change -186.34%
% of Operating Profit
Other Income/Expense, Net $11.32M
YoY Change -96.64%
Pretax Income -$98.30M
YoY Change -142.86%
Income Tax $23.05M
% Of Pretax Income
Net Earnings -$121.4M
YoY Change -156.33%
Net Earnings / Revenue -12.12%
Basic Earnings Per Share -$0.09
Diluted Earnings Per Share -$0.09
COMMON SHARES
Basic Shares Outstanding 1.386B shares 1.380B shares
Diluted Shares Outstanding 1.377B shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $2.702B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $431.7M
Prepaid Expenses
Receivables $569.0M
Other Receivables
Total Short-Term Assets $3.912B
YoY Change -3.5%
LONG-TERM ASSETS
Property, Plant & Equipment $1.563B
YoY Change 32.68%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $35.23M
YoY Change 28.94%
Other Assets $201.2M
YoY Change 42.78%
Total Long-Term Assets $1.919B
YoY Change 30.43%
TOTAL ASSETS
Total Short-Term Assets $3.912B
Total Long-Term Assets $1.919B
Total Assets $5.831B
YoY Change 5.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $307.5M
YoY Change -10.04%
Accrued Expenses $717.3M
YoY Change 41.82%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due 6.062B cnies
YoY Change 152.7%
Total Short-Term Liabilities $2.025B
YoY Change 57.82%
LONG-TERM LIABILITIES
Long-Term Debt 1.316B cnies
YoY Change -10.99%
Other Long-Term Liabilities $50.57M
YoY Change 20.44%
Total Long-Term Liabilities $369.5M
YoY Change -22.76%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.025B
Total Long-Term Liabilities $369.5M
Total Liabilities $2.395B
YoY Change 35.94%
SHAREHOLDERS EQUITY
Retained Earnings -$8.455B
YoY Change 11.33%
Common Stock $138.0K
YoY Change 2.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.436B
YoY Change
Total Liabilities & Shareholders Equity $5.831B
YoY Change 5.54%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$121.4M
YoY Change -156.33%
Depreciation, Depletion And Amortization $70.03M
YoY Change 263.93%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
KY1-1108
dei Local Phone Number
LocalPhoneNumber
949-4123
dei Security12b Title
Security12bTitle
American Depositary Shares, each representing 13 Ordinary Shares, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
BGNE
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1386034320 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3537327000 usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei City Area Code
CityAreaCode
345
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4383355000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
215413000 usd
us-gaap Net Income Loss
NetIncomeLoss
-492905000 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Address Address Line1
EntityAddressAddressLine1
c/o Mourant Governance Services (Cayman) Limited
dei Entity Address Address Line2
EntityAddressAddressLine2
94 Solaris Avenue, Camana Bay
dei Entity Address City Or Town
EntityAddressCityOrTown
Grand Cayman
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Registrant Name
EntityRegistrantName
BEIGENE, LTD.
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1001599000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1411283000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1284607000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
455223000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
365708000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1326379000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1089616000 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1376751873 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1361216763 shares
CY2023Q3 bgne Earnings Per American Depository Share Diluted
EarningsPerAmericanDepositoryShareDiluted
2.01
bgne Earnings Per American Depository Share Diluted
EarningsPerAmericanDepositoryShareDiluted
-4.92
bgne Weighted Average Number Of American Depository Shares Outstanding Diluted
WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted
104708982 shares
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3080892000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
28657000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
75322000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
18403000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-348431000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001651308
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1209416
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
781308000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2682417000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1824370000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
831137000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
684999000 usd
us-gaap Gross Profit
GrossProfit
2248888000 usd
us-gaap Gross Profit
GrossProfit
1550282000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
496179000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
453259000 usd
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
951402000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
818967000 usd
us-gaap Costs And Expenses
CostsAndExpenses
2737662000 usd
us-gaap Costs And Expenses
CostsAndExpenses
2374223000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-120265000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-133968000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-488774000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-823941000 usd
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
10643000 usd
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
26649000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
40028000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
57735000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11318000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
336657000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1096000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
291142000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-98304000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
229338000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-447650000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-475064000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23046000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13925000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45255000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39091000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-121350000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
215413000 usd
us-gaap Net Income Loss
NetIncomeLoss
-492905000 usd
us-gaap Net Income Loss
NetIncomeLoss
-514155000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1376751873 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1360716279 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1361216763 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1358392470 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1390331833 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1358392470 shares
CY2024Q3 bgne Earnings Per American Depository Share Basic
EarningsPerAmericanDepositoryShareBasic
-1.15
CY2023Q3 bgne Earnings Per American Depository Share Basic
EarningsPerAmericanDepositoryShareBasic
2.06
bgne Earnings Per American Depository Share Basic
EarningsPerAmericanDepositoryShareBasic
-4.71
bgne Earnings Per American Depository Share Basic
EarningsPerAmericanDepositoryShareBasic
-4.92
CY2024Q3 bgne Earnings Per American Depository Share Diluted
EarningsPerAmericanDepositoryShareDiluted
-1.15
bgne Earnings Per American Depository Share Diluted
EarningsPerAmericanDepositoryShareDiluted
-4.71
CY2024Q3 bgne Weighted Average Number Of American Depository Shares Outstanding Basic
WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic
105903990 shares
CY2023Q3 bgne Weighted Average Number Of American Depository Shares Outstanding Basic
WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic
104670483 shares
bgne Weighted Average Number Of American Depository Shares Outstanding Basic
WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic
104708982 shares
bgne Weighted Average Number Of American Depository Shares Outstanding Basic
WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic
104491728 shares
CY2024Q3 bgne Weighted Average Number Of American Depository Shares Outstanding Diluted
WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted
105903990 shares
CY2023Q3 bgne Weighted Average Number Of American Depository Shares Outstanding Diluted
WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted
106948603 shares
bgne Weighted Average Number Of American Depository Shares Outstanding Diluted
WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted
104491728 shares
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-121350000 usd
us-gaap Net Income Loss
NetIncomeLoss
-514155000 usd
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
56747000 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2559000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
15348000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-75732000 usd
CY2024Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-202000 usd
CY2023Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
0 usd
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-608000 usd
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
0 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1315000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-35000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
8218000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-64401000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
214169000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-476984000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-581669000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2701933000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3171800000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
569047000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
358027000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
431676000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
416122000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
209080000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
257465000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
3911736000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
4203414000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1562965000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1324154000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
101046000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
95207000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
53939000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
57138000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
201174000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
125362000 usd
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
1919124000 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1601861000 usd
CY2024Q3 us-gaap Assets
Assets
5830860000 usd
CY2023Q4 us-gaap Assets
Assets
5805275000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
307532000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
315111000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
717343000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
693731000 usd
CY2024Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
14880000 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
22951000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
17707000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
21950000 usd
CY2024Q3 bgne Research And Development Cost Share Liability Current Portion
ResearchAndDevelopmentCostShareLiabilityCurrentPortion
104067000 usd
CY2023Q4 bgne Research And Development Cost Share Liability Current Portion
ResearchAndDevelopmentCostShareLiabilityCurrentPortion
68004000 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
863803000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
688366000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2025332000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1810113000 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
187513000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
197618000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
32454000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
22251000 usd
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15935000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
16494000 usd
CY2024Q3 bgne Research And Development Cost Share Liability Noncurrent Portion
ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion
82985000 usd
CY2023Q4 bgne Research And Development Cost Share Liability Noncurrent Portion
ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion
170662000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
50568000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
50810000 usd
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
369455000 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
457835000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
2394787000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2267948000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
9500000000 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
9500000000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1386034320 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1386034320 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1359513224 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1359513224 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
138000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
135000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11974415000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11598688000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-83525000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-99446000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8454955000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7962050000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
3436073000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3537327000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5830860000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5805275000 usd
us-gaap Net Income Loss
NetIncomeLoss
-492905000 usd
us-gaap Net Income Loss
NetIncomeLoss
-514155000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
121516000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
63856000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
334001000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
274697000 usd
bgne Acquired In Process Research And Development
AcquiredInProcessResearchAndDevelopment
0 usd
bgne Acquired In Process Research And Development
AcquiredInProcessResearchAndDevelopment
15000000 usd
bgne Amortization Of Research And Development Financing Liability
AmortizationOfResearchAndDevelopmentFinancingLiability
-51614000 usd
bgne Amortization Of Research And Development Financing Liability
AmortizationOfResearchAndDevelopmentFinancingLiability
-38569000 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
362917000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
11516000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
13830000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
203744000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
143511000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12112000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
52371000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-9505000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
17598000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
13536000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
31366000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
54638000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
50089000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
477000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-255587000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-605000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
55000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-215791000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-935815000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
400183000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
404937000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
4674000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
9413000 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
2655000 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
567519000 usd
bgne Payments To Purchase In Process Research And Development
PaymentsToPurchaseInProcessResearchAndDevelopment
31800000 usd
bgne Payments To Purchase In Process Research And Development
PaymentsToPurchaseInProcessResearchAndDevelopment
15000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
20743000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
15581000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-454745000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
122588000 usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
9053000 usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
22502000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
17581000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
8462000 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
324412000 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
162614000 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
157490000 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
159576000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
36578000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
52352000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
3000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
197972000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
69430000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-50348000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-472556000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-794145000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3185984000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3875037000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2713428000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2701933000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3067336000 usd
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
9284000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
11548000 usd
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2211000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2008000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
54778000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
42516000 usd
us-gaap Interest Paid Net
InterestPaidNet
38162000 usd
us-gaap Interest Paid Net
InterestPaidNet
15893000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
75317000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
107611000 usd
bgne Noncash Investing And Financing Items Increase In Equity Investment
NoncashInvestingAndFinancingItemsIncreaseInEquityInvestment
40798000 usd
bgne Noncash Investing And Financing Items Increase In Equity Investment
NoncashInvestingAndFinancingItemsIncreaseInEquityInvestment
0 usd
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
0 usd
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
9384000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
15663000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
88667000 usd
CY2024Q1 bgne Adjustments To Additional Paid In Capital Deconsolidation Of Subsidiary
AdjustmentsToAdditionalPaidInCapitalDeconsolidationOfSubsidiary
2052000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-32198000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-251150000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
3360361000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
4492000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
130637000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-8830000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-120405000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
3366255000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
19522000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
114697000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
56949000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-121350000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
3436073000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
4157306000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3692000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
103371000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-84673000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-381137000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
3798559000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
17419000 usd
CY2023Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
362917000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
96004000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1244000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
215413000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3763234000 usd
CY2024Q3 bgne Number Of Approved Medicines
NumberOfApprovedMedicines
3 medicine
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Areas where management uses subjective judgment include, but are not limited to, estimating the useful lives of long-lived assets, estimating variable consideration in product sales and collaboration revenue arrangements, identifying separate accounting units and determining the standalone selling price of each performance obligation in the Company’s revenue arrangements, assessing the impairment of long-lived assets, valuation and recognition of share-based compensation expenses, realizability of deferred tax assets, estimating uncertain tax positions, valuation of inventory, estimating the allowance for credit losses, determining defined benefit pension plan obligations, measurement of right-of-use assets and lease liabilities and the fair value of financial instruments. Management bases the estimates on historical experience, known trends and various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities and reported amounts of revenues and expenses. Actual results could differ from these estimates.</span></div>
CY2024Q3 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024Q3 bgne Reimbursement Expense
ReimbursementExpense
11632000 usd
CY2023Q3 bgne Reimbursement Expense
ReimbursementExpense
11089000 usd
bgne Reimbursement Expense
ReimbursementExpense
33870000 usd
bgne Reimbursement Expense
ReimbursementExpense
37981000 usd
CY2024Q3 bgne Upfront And Milestone Payments
UpfrontAndMilestonePayments
5000000 usd
CY2023Q3 bgne Upfront And Milestone Payments
UpfrontAndMilestonePayments
24379000 usd
bgne Upfront And Milestone Payments
UpfrontAndMilestonePayments
51527000 usd
bgne Upfront And Milestone Payments
UpfrontAndMilestonePayments
33612000 usd
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
9284000 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
11473000 usd
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2211000 usd
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2711000 usd
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
11495000 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
14184000 usd
CY2024Q3 us-gaap Equity Method Investments
EquityMethodInvestments
35233000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
25981000 usd
CY2024Q3 us-gaap Equity Securities Fv Ni And Without Readily Determinable Fair Value
EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue
133239000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni And Without Readily Determinable Fair Value
EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue
85429000 usd
CY2024Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
494000 usd
CY2023Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-2291000 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-1539000 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-2927000 usd
CY2024Q3 bgne Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount Net
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmountNet
0 usd
CY2023Q3 bgne Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount Net
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmountNet
5522000 usd
bgne Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount Net
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmountNet
797000 usd
bgne Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount Net
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmountNet
4441000 usd
CY2024Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2936000 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2675000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7809000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5299000 usd
CY2024Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
147297000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
148772000 usd
CY2024Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
61985000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
39098000 usd
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
222394000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
228252000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
431676000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
416122000 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1303487000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
832751000 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
366165000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
249212000 usd
CY2024Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
625643000 usd
CY2023Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
740615000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1562965000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1324154000 usd
CY2024Q3 us-gaap Depreciation
Depreciation
70028000 usd
us-gaap Depreciation
Depreciation
117892000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
19242000 usd
us-gaap Depreciation
Depreciation
59574000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
73798000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
19859000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
53939000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
73261000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16123000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
57138000 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1264000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2268000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3624000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4282000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1221000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
4879000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
4879000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
4879000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
4879000 usd
CY2024Q3 bgne Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
33202000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
53939000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23046000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45255000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13925000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39091000 usd
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
17592000 usd
CY2024Q3 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
1788000 usd
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
3328000 usd
CY2024Q3 bgne Prepaid Research And Development Costs
PrepaidResearchAndDevelopmentCosts
60227000 usd
CY2023Q4 bgne Prepaid Research And Development Costs
PrepaidResearchAndDevelopmentCosts
60476000 usd
CY2024Q3 us-gaap Prepaid Taxes
PrepaidTaxes
25048000 usd
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
37320000 usd
CY2024Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
33967000 usd
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
37859000 usd
CY2024Q3 bgne Prepaid Manufacturing Costs
PrepaidManufacturingCosts
28849000 usd
CY2023Q4 bgne Prepaid Manufacturing Costs
PrepaidManufacturingCosts
42066000 usd
CY2024Q3 bgne Prepaid General And Administrative Expenses Current
PrepaidGeneralAndAdministrativeExpensesCurrent
16183000 usd
CY2023Q4 bgne Prepaid General And Administrative Expenses Current
PrepaidGeneralAndAdministrativeExpensesCurrent
14619000 usd
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
9284000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
11473000 usd
CY2024Q3 us-gaap Deposits Assets Current
DepositsAssetsCurrent
7860000 usd
CY2023Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
26753000 usd
CY2024Q3 us-gaap Prepaid Insurance
PrepaidInsurance
6180000 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
8872000 usd
CY2024Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
21482000 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
18027000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
209080000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
257465000 usd
CY2024Q3 bgne Prepayment Of Long Term Asset
PrepaymentOfLongTermAsset
35963000 usd
CY2023Q4 bgne Prepayment Of Long Term Asset
PrepaymentOfLongTermAsset
4144000 usd
CY2024Q3 bgne Prepaid Supply Cost
PrepaidSupplyCost
12779000 usd
CY2023Q4 bgne Prepaid Supply Cost
PrepaidSupplyCost
18122000 usd
CY2024Q3 bgne Rental Deposits And Other
RentalDepositsAndOther
9180000 usd
CY2023Q4 bgne Rental Deposits And Other
RentalDepositsAndOther
8195000 usd
CY2024Q3 us-gaap Value Added Tax Receivable Noncurrent
ValueAddedTaxReceivableNoncurrent
2807000 usd
CY2023Q4 us-gaap Value Added Tax Receivable Noncurrent
ValueAddedTaxReceivableNoncurrent
2546000 usd
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2211000 usd
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2711000 usd
CY2024Q3 us-gaap Long Term Investments
LongTermInvestments
138234000 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
89644000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
201174000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
125362000 usd
CY2024Q3 bgne Accrued Sales Rebates And Returns Current
AccruedSalesRebatesAndReturnsCurrent
213747000 usd
CY2023Q4 bgne Accrued Sales Rebates And Returns Current
AccruedSalesRebatesAndReturnsCurrent
139936000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
211856000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
217803000 usd
CY2024Q3 bgne Accrued Liabilities External Research And Development
AccruedLiabilitiesExternalResearchAndDevelopment
112077000 usd
CY2023Q4 bgne Accrued Liabilities External Research And Development
AccruedLiabilitiesExternalResearchAndDevelopment
162969000 usd
CY2024Q3 bgne Accrued Expenses Commercial Activities
AccruedExpensesCommercialActivities
80810000 usd
CY2023Q4 bgne Accrued Expenses Commercial Activities
AccruedExpensesCommercialActivities
87572000 usd
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
34550000 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
30083000 usd
CY2024Q3 bgne Accrued General And Administrative Expenses Current
AccruedGeneralAndAdministrativeExpensesCurrent
30830000 usd
CY2023Q4 bgne Accrued General And Administrative Expenses Current
AccruedGeneralAndAdministrativeExpensesCurrent
36203000 usd
CY2024Q3 bgne Accrued Professional Fees And Other Current
AccruedProfessionalFeesAndOtherCurrent
33473000 usd
CY2023Q4 bgne Accrued Professional Fees And Other Current
AccruedProfessionalFeesAndOtherCurrent
19165000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
717343000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
693731000 usd
CY2024Q3 bgne Government Grants Or Incentives Received And Deferred Noncurrent
GovernmentGrantsOrIncentivesReceivedAndDeferredNoncurrent
32429000 usd
CY2023Q4 bgne Government Grants Or Incentives Received And Deferred Noncurrent
GovernmentGrantsOrIncentivesReceivedAndDeferredNoncurrent
34204000 usd
CY2024Q3 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
13022000 usd
CY2023Q4 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
14995000 usd
CY2024Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
1140000 usd
CY2023Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
1127000 usd
CY2024Q3 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
3977000 usd
CY2023Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
484000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
50568000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
50810000 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
863803000 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
6061776000 cny
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
688366000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4885838000 cny
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
187513000 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1315880000 cny
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
197618000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1402643000 cny
CY2024Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
14312000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
39949000 usd
CY2024Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
8176000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
25697000 usd
CY2023Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
6630000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
16095000 usd
CY2023Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
11632000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
12404000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-121350000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
215413000 usd
us-gaap Net Income Loss
NetIncomeLoss
-492905000 usd
us-gaap Net Income Loss
NetIncomeLoss
-514155000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1376751873 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1360716279 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1361216763 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1358392470 shares
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
29615554 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1376751873 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1390331833 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1361216763 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1358392470 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
114603000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
96119000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
334011000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
274836000 usd
us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
15313000 usd
us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
-608000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
15921000 usd
CY2024Q3 bgne Restricted Net Assets Minimum Required Statutory Reserve Of Annual After Tax Profit Percentage
RestrictedNetAssetsMinimumRequiredStatutoryReserveOfAnnualAfterTaxProfitPercentage
0.10
CY2024Q3 bgne Restricted Net Assets Required Statutory Reserve As Percentage Of Registered Capital
RestrictedNetAssetsRequiredStatutoryReserveAsPercentageOfRegisteredCapital
0.50
CY2024Q3 bgne Restricted Net Assets Minimum Required Statutory Reserve Of Annual After Tax Profit Percentage
RestrictedNetAssetsMinimumRequiredStatutoryReserveOfAnnualAfterTaxProfitPercentage
0.10
us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
155852000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1001599000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
781308000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2682417000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1824370000 usd
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001651308-24-000152-index-headers.html Edgar Link pending
0001651308-24-000152-index.html Edgar Link pending
0001651308-24-000152.txt Edgar Link pending
0001651308-24-000152-xbrl.zip Edgar Link pending
bgne-20240930.htm Edgar Link pending
bgne-20240930.xsd Edgar Link pending
bgne-20240930_g1.jpg Edgar Link pending
exhibit311-2024q3.htm Edgar Link pending
exhibit312-2024q3.htm Edgar Link pending
exhibit321-2024q3.htm Edgar Link pending
bgne-20240930_cal.xml Edgar Link unprocessable
bgne-20240930_def.xml Edgar Link unprocessable
bgne-20240930_pre.xml Edgar Link unprocessable
bgne-20240930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bgne-20240930_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending